Literature DB >> 19648110

Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK.

Elizabeth M King1, Neil S Holden, Wei Gong, Christopher F Rider, Robert Newton.   

Abstract

Acting via the glucocorticoid receptor (GR), glucocorticoids exert potent anti-inflammatory effects partly by repressing inflammatory gene transcription occurring via factors such as NF-kappaB. In the present study, the synthetic glucocorticoid, dexamethasone, induces expression of MKP-1 (mitogen-activated protein kinase (MAPK) phosphatase-1) in human bronchial epithelial (BEAS-2B) and pulmonary (A549) cells. This correlates with reduced TNFalpha-stimulated p38 MAPK phosphorylation. Since NF-kappaB-dependent transcription and IL-8 protein, mRNA, and unspliced RNA (a surrogate of transcription rate) are sensitive to p38 MAPK inhibitors (SB203580 and SB239063), we explored the role of MKP-1 in repression of these outputs. Repression of TNFalpha-induced p38 MAPK phosphorylation, NF-kappaB-dependent transcription, and IL-8 expression by dexamethasone are sensitive to transcriptional or translational inhibitors. This indicates a role for de novo gene synthesis. Adenoviral expression of MKP-1 profoundly reduces p38 MAPK phosphorylation and IL-8 expression. Similarly, NF-kappaB-dependent transcription is significantly reduced to levels consistent with maximal p38 MAPK inhibition. Thus, MKP-1 attenuates TNFalpha-dependent activation of p38 MAPK, induction of IL-8 expression, and NF-kappaB-dependent transcription. Small interfering RNA knockdown of dexamethasone-induced MKP-1 expression partially reverses the repression of TNFalpha-activated p38 MAPK, demonstrating that MKP-1 participates in the dexamethasone-dependent repression of this pathway. In the presence of MKK6 (MAPK kinase 6), a p38 MAPK activator, dexamethasone dramatically represses TNFalpha-induced NF-kappaB-dependent transcription, and this is significantly reversed by MKP-1-targeting small interfering RNA. This reveals an important and novel role for transcriptional activation (transactivation) of MKP-1 in the repression of NF-kappaB-dependent transcription by glucocorticoids. We conclude that GR transactivation is essential to the anti-inflammatory properties of GR ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648110      PMCID: PMC2785369          DOI: 10.1074/jbc.M109.028381

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

Review 2.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

4.  Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB.

Authors:  E Ayroldi; G Migliorati; S Bruscoli; C Marchetti; O Zollo; L Cannarile; F D'Adamio; C Riccardi
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

5.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.

Authors:  O Kassel; A Sancono; J Krätzschmar; B Kreft; M Stassen; A C Cato
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

6.  SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

Authors:  D C Underwood; R R Osborn; S Bochnowicz; E F Webb; D J Rieman; J C Lee; A M Romanic; J L Adams; D W Hay; D E Griswold
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

7.  Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

Authors:  K Ito; P J Barnes; I M Adcock
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.

Authors:  O F Bueno; L J De Windt; H W Lim; K M Tymitz; S A Witt; T R Kimball; J D Molkentin
Journal:  Circ Res       Date:  2001-01-19       Impact factor: 17.367

9.  p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex.

Authors:  K Ito; E Jazrawi; B Cosio; P J Barnes; I M Adcock
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

10.  Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells.

Authors:  R Newton; L A Hart; D A Stevens; M Bergmann; L E Donnelly; I M Adcock; P J Barnes
Journal:  Eur J Biochem       Date:  1998-05-15
View more
  60 in total

1.  Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model.

Authors:  Eleuza R Machado; Daniela Carlos; Carlos A Sorgi; Simone G Ramos; Daniela I Souza; Edson G Soares; Julia M Costa-Cruz; Marlene T Ueta; David M Aronoff; Lúcia H Faccioli
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Myeloma cells contain high levels of inorganic polyphosphate which is associated with nucleolar transcription.

Authors:  Maria D Jimenez-Nuñez; David Moreno-Sanchez; Laura Hernandez-Ruiz; Alicia Benítez-Rondán; Ana Ramos-Amaya; Beatriz Rodríguez-Bayona; Francisco Medina; José Antonio Brieva; Felix A Ruiz
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 4.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

5.  MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1.

Authors:  Hong Yu; Yuhao Sun; Courtney Haycraft; Viswanathan Palanisamy; Keith L Kirkwood
Journal:  Cytokine       Date:  2011-07-05       Impact factor: 3.861

6.  The characteristic long-term upregulation of hippocampal NF-κB complex in PTSD-like behavioral stress response is normalized by high-dose corticosterone and pyrrolidine dithiocarbamate administered immediately after exposure.

Authors:  Hagit Cohen; Nitsan Kozlovsky; Michael A Matar; Joseph Zohar; Zeev Kaplan
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

7.  Prostaglandins mediate zymosan-induced sickness behavior in mice.

Authors:  Juliana B M Lima; Clarice C Veloso; Fabiana C Vilela; Alexandre Giusti-Paiva
Journal:  J Physiol Sci       Date:  2016-10-03       Impact factor: 2.781

8.  Endothelial glucocorticoid receptor is required for protection against sepsis.

Authors:  Julie E Goodwin; Yan Feng; Heino Velazquez; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

9.  Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.

Authors:  K Lei; E X Georgiou; L Chen; A Yulia; S R Sooranna; J J Brosens; P R Bennett; M R Johnson
Journal:  Mol Endocrinol       Date:  2015-08-17

Review 10.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.